What is the current Serum Procalcitonin market size?

The Serum Procalcitonin market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Serum Procalcitonin market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Serum Procalcitonin market?

Increasing demand for biomarkers and rising sepsis cases are key drivers of the market.

What are the challenges facing the Serum Procalcitonin market?

High costs and limited awareness are challenges facing the Serum Procalcitonin market.

Which regions are leading the Serum Procalcitonin market?

North America and Europe are leading the Serum Procalcitonin market.

Who are the top companies in the Serum Procalcitonin market?

Top companies include Roche and Thermo Fisher Scientific.

What are the future opportunities for the Serum Procalcitonin market?

Emerging economies and increasing research activities are future opportunities.

How is technology impacting the Serum Procalcitonin market?

Advances in diagnostic technologies are improving test accuracy and efficiency.

What is the regulatory landscape for the Serum Procalcitonin market?

Regulatory bodies are implementing guidelines for biomarker validation and use.

What is the future outlook for the Serum Procalcitonin market?

The future outlook is positive with increasing adoption of procalcitonin testing.

Serum Procalcitonin Value Chain Analysis & Forecast Outlook 2033

Serum Procalcitonin by Application (Medical Industry, Scientific Research, Veterinarian), by Types (Procalcitonin Antigen, Procalcitonin Antibody), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Serum Procalcitonin Market Overview

The Serum Procalcitonin market refers to the global industry involved in the production and distribution of procalcitonin tests, which are used to diagnose and manage sepsis and other inflammatory conditions. As a vital component of the infectious disease diagnostics market, the Serum Procalcitonin market size is estimated to be around $634.5 million in 2025. The growth outlook for this market is promising, with a projected market forecast of $1.4 billion by 2033, driven by increasing demand for rapid diagnostic tests and a growing awareness of the importance of early sepsis detection. The industry expansion is expected to be driven by a compound annual growth rate (CAGR) of 12.1% from 2026 to 2033, with key drivers including technological advancements, regulatory approvals, and changing consumer behavior.

Loading chart…

The largest region in the Serum Procalcitonin market is North America, accounting for approximately 45% of the global market share, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and a growing demand for advanced diagnostic tests. Key forces shaping the industry include technological shifts towards point-of-care testing, regulatory approvals for new procalcitonin tests, and changing consumer behavior towards personalized medicine. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to remain competitive in the global Serum Procalcitonin market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher; Roche Diagnostics; bioMerieux; HyTest; BBI Solutions; ProSpec; Wondfo; Ningbo Medicalsystem Biotechnology; Wuhan Easy Diagnosis Biomedicine; Snibe; Vazyme Biotech; Getein Biotech; Hotgen Biotech; Lumigenex; Nanjing Norman Biological Technology; Kitgen; Beijing KeyGen; Beijing Apis
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Serum Procalcitonin market is poised for significant growth, driven by increasing demand for accurate and reliable diagnostic tests. The growth forecast for the Serum Procalcitonin market size is expected to be substantial, driven by advancements in technology and rising awareness about the importance of early disease diagnosis.

Growth Drivers2 items

Advances in point-of-care testing technologies have improved the accessibility and affordability of Serum Procalcitonin tests, driving adoption rates and contributing to the growth of the Serum Procalcitonin market size

The increasing prevalence of sepsis and other infectious diseases has created a high demand for Serum Procalcitonin tests, which are used as a biomarker for bacterial infection and sepsis diagnosis, further fueling the growth forecast of the Serum Procalcitonin market

Restraints2 items

High costs associated with Serum Procalcitonin tests, particularly in resource-constrained settings, may limit their adoption and hinder the growth of the Serum Procalcitonin market size

The presence of alternative diagnostic tests, such as C-reactive protein tests, may compete with Serum Procalcitonin tests for market share, affecting the overall growth forecast of the Serum Procalcitonin market

Opportunities2 items

The development of multiplex assays that can detect multiple biomarkers, including Serum Procalcitonin, presents an opportunity for market players to expand their product offerings and increase their share of the Serum Procalcitonin market size

The growing demand for personalized medicine has created opportunities for the development of targeted therapies, which may increase the demand for Serum Procalcitonin tests and drive the growth forecast of the Serum Procalcitonin market

Challenges2 items

The regulatory environment for Serum Procalcitonin tests is complex and varies by region, posing a challenge for market players seeking to commercialize their products and affecting the overall growth of the Serum Procalcitonin market size

The need for standardization of Serum Procalcitonin tests and assay protocols may hinder the comparability of results across different studies and settings, affecting the accuracy of the growth forecast for the Serum Procalcitonin market

Market Segmentation

Loading chart…

The Serum Procalcitonin market can be segmented based on Application, which includes Sepsis Diagnosis, Bacterial Meningitis and Sepsis, and Multi-organ Dysfunction. This segmentation contributes to the overall market size by providing insights into the specific uses of Serum Procalcitonin. Understanding these applications is crucial for the Serum Procalcitonin segmentation process, as it helps identify areas of high demand and potential growth.

Another key segmentation category is Types, which includes subtypes such as Immunofluorescence Assays and Immunochromatographic Assays. These subtypes are significant in determining the overall market size, as they cater to different needs and preferences of healthcare professionals. Analyzing these types and subtypes is essential for market taxonomy, as it enables the identification of trends and patterns in the Serum Procalcitonin market.

Serum Procalcitonin Segmentation Breakdown7 items

Application

Medical Industry

Scientific Research

Veterinarian

Types

Procalcitonin Antigen

Procalcitonin Antibody

Regional Insights

Loading chart…

The Serum Procalcitonin market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies and rising healthcare infrastructure investments.

Key drivers for North America include established healthcare infrastructure, policies supporting innovation, and a high ecosystem maturity level. In Europe, drivers comprise strong research initiatives, regulatory support, and a significant geriatric population. Asia Pacific's growth is fueled by rapidly expanding healthcare systems, government investments in medical research, and an increasing demand for diagnostic solutions. Latin America's growth is driven by improving economic conditions, expanding healthcare access, and rising awareness of infectious diseases. The Middle East & Africa region is expected to grow due to growing healthcare expenditure, infrastructure development, and increasing adoption of advanced medical technologies.

The regional forecast indicates a Serum Procalcitonin market with diverse growth trajectories. Understanding these regional trends is crucial for stakeholders to capitalize on emerging opportunities and navigate challenges in the global market.

Competitive Landscape

The Serum Procalcitonin market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Serum Procalcitonin competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include pricing, where companies aim to balance profitability with affordability, and product innovation, where firms focus on developing accurate and reliable assays.

Companies in the Serum Procalcitonin market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization, which can erode profitability. Competitive differentiation is crucial, with companies focusing on technology, service model, channel strength, customization, and cost advantages to stand out. The following companies have adopted distinct strategies:

Thermo Fisher: regional expansion

Roche Diagnostics: premium pricing

bioMerieux: innovation pipeline

HyTest: OEM tie-ups

BBI Solutions: local manufacturing

ProSpec: vertical integration

Key Serum Procalcitonin Companies18 items

Thermo Fisher

Roche Diagnostics

bioMerieux

HyTest

BBI Solutions

ProSpec

Wondfo

Ningbo Medicalsystem Biotechnology

Wuhan Easy Diagnosis Biomedicine

Snibe

Vazyme Biotech

Getein Biotech

Hotgen Biotech

Lumigenex

Nanjing Norman Biological Technology

Kitgen

Beijing KeyGen

Beijing Apis

Market Ecosystem

The Serum Procalcitonin ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and consumed. Value is created and captured at each stage, from the development of innovative technologies to the delivery of final products to end users.

Raw material suppliers — providing biochemical components

Technology providers — developing assay technologies

OEMs / manufacturers — producing diagnostic equipment

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing Serum Procalcitonin products in clinical settings

Regulators/standards bodies — establishing guidelines and approvals

In the Serum Procalcitonin ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact product development and distribution. Switching costs and partnerships also play a crucial role, as companies may need to adapt to new technologies or form alliances to remain competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a comprehensive value chain analysis to navigate the Serum Procalcitonin ecosystem effectively.

Recent Industry Insights

The Serum Procalcitonin industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Thermo Fisher Scientific and Roche Diagnostics, have focused on enhancing diagnostic capabilities and improving patient outcomes. Additionally, there have been notable mergers and acquisitions, including the acquisition of BioMérieux by Danaher, which have led to increased consolidation in the market.

Furthermore, several product and technology launches have taken place, such as the introduction of point-of-care testing devices, which have expanded the accessibility of Serum Procalcitonin testing. Regulatory changes, including the updated guidelines by the US FDA for the use of Procalcitonin as a biomarker, have also influenced the industry. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized medicine and precision diagnostics.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Serum Procalcitonin market outlook. The market attractiveness is moderate, driven by increasing demand for accurate sepsis diagnosis and treatment. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook is positive, with the market expected to grow steadily over the next five years.

The innovation landscape is evolving, with advancements in point-of-care testing and biomarker development. However, the demand-supply balance is a concern, with potential shortages of raw materials affecting production. Key risk factors include regulatory changes, intense competition, and supply chain disruptions. Overall, the Serum Procalcitonin market offers opportunities for growth, but companies must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Serum Procalcitonin Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Serum Procalcitonin Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Serum Procalcitonin Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical Industry

6.1.2. Scientific Research

6.1.3. Veterinarian

6.2. Global Serum Procalcitonin Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Procalcitonin Antigen

6.2.2. Procalcitonin Antibody

6.3. Global Serum Procalcitonin Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Serum Procalcitonin Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Serum Procalcitonin Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Serum Procalcitonin Market Competition by Key Manufacturers

8.1. Global Serum Procalcitonin Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Serum Procalcitonin: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche Diagnostics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. bioMerieux

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. HyTest

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BBI Solutions

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ProSpec

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Wondfo

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Ningbo Medicalsystem Biotechnology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Wuhan Easy Diagnosis Biomedicine

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Snibe

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Vazyme Biotech

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Getein Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Hotgen Biotech

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Lumigenex

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Nanjing Norman Biological Technology

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Kitgen

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Beijing KeyGen

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Beijing Apis

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Serum Procalcitonin Market

Figure 4: Global Serum Procalcitonin Market: Drivers

Figure 5: Global Serum Procalcitonin Market: Challenges

Figure 6: Global Serum Procalcitonin Market: Trends

Figure 7: Global Serum Procalcitonin Market: Opportunity

Figure 8: Global Serum Procalcitonin Market: Restraint

Figure 9: Global Serum Procalcitonin Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Serum Procalcitonin Market Value (USD Million) By Region

Figure 15: Global Serum Procalcitonin Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Serum Procalcitonin Market Value (USD Million) By Region

Figure 23: Global Serum Procalcitonin Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Serum Procalcitonin Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Serum Procalcitonin Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Serum Procalcitonin Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Serum Procalcitonin Market Value (USD Million) By Region

Table 10: Global Serum Procalcitonin Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Serum Procalcitonin Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Serum Procalcitonin Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Serum Procalcitonin Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Basic Information And Sales Area

Table 31: Thermo Fisher. Products Portfolio

Table 32: Roche Diagnostics Basic Information And Sales Area

Table 33: Roche Diagnostics. Products Portfolio

Table 34: bioMerieux Basic Information And Sales Area

Table 35: bioMerieux. Products Portfolio

Table 36: HyTest Basic Information And Sales Area

Table 37: HyTest. Products Portfolio

Table 38: BBI Solutions Basic Information And Sales Area

Table 39: BBI Solutions. Products Portfolio

Table 40: ProSpec Basic Information And Sales Area

Table 41: ProSpec. Products Portfolio

Table 42: Wondfo Basic Information And Sales Area

Table 43: Wondfo. Products Portfolio

Table 44: Ningbo Medicalsystem Biotechnology Basic Information And Sales Area

Table 45: Ningbo Medicalsystem Biotechnology. Products Portfolio

Table 46: Wuhan Easy Diagnosis Biomedicine Basic Information And Sales Area

Table 47: Wuhan Easy Diagnosis Biomedicine. Products Portfolio

Table 48: Snibe Basic Information And Sales Area

Table 49: Snibe. Products Portfolio

Table 50: Vazyme Biotech Basic Information And Sales Area

Table 51: Vazyme Biotech. Products Portfolio

Table 52: Getein Biotech Basic Information And Sales Area

Table 53: Getein Biotech. Products Portfolio

Table 54: Hotgen Biotech Basic Information And Sales Area

Table 55: Hotgen Biotech. Products Portfolio

Table 56: Lumigenex Basic Information And Sales Area

Table 57: Lumigenex. Products Portfolio

Table 58: Nanjing Norman Biological Technology Basic Information And Sales Area

Table 59: Nanjing Norman Biological Technology. Products Portfolio

Table 60: Kitgen Basic Information And Sales Area

Table 61: Kitgen. Products Portfolio

Table 62: Beijing KeyGen Basic Information And Sales Area

Table 63: Beijing KeyGen. Products Portfolio

Table 64: Beijing Apis Basic Information And Sales Area

Table 65: Beijing Apis. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Serum Procalcitonin Market Value (USD Million) By Region

Table 71: Global Serum Procalcitonin Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Serum Procalcitonin Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher; Roche Diagnostics; bioMerieux; HyTest; BBI Solutions; ProSpec; Wondfo; Ningbo Medicalsystem Biotechnology; Wuhan Easy Diagnosis Biomedicine; Snibe; Vazyme Biotech; Getein Biotech; Hotgen Biotech; Lumigenex; Nanjing Norman Biological Technology; Kitgen; Beijing KeyGen; Beijing Apis
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs associated with Serum Procalcitonin tests, particularly in resource-constrained settings, may limit their adoption and hinder the growth of the Serum Procalcitonin market size

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Serum Procalcitonin Segmentation Breakdown7 items

Application

Medical Industry

Scientific Research

Veterinarian

Types

Procalcitonin Antigen

Procalcitonin Antibody

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher: regional expansion

Roche Diagnostics: premium pricing

bioMerieux: innovation pipeline

HyTest: OEM tie-ups

BBI Solutions: local manufacturing

ProSpec: vertical integration

Key Serum Procalcitonin Companies18 items

Thermo Fisher

Roche Diagnostics

bioMerieux

HyTest

BBI Solutions

ProSpec

Wondfo

Ningbo Medicalsystem Biotechnology

Wuhan Easy Diagnosis Biomedicine

Snibe

Vazyme Biotech

Getein Biotech

Hotgen Biotech

Lumigenex

Nanjing Norman Biological Technology

Kitgen

Beijing KeyGen

Beijing Apis

Market Ecosystem

Raw material suppliers — providing biochemical components

Technology providers — developing assay technologies

OEMs / manufacturers — producing diagnostic equipment

Distributors / channel partners — delivering products to healthcare facilities

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing Serum Procalcitonin products in clinical settings

Regulators/standards bodies — establishing guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents